29078-20-4

Basic information

• Product Name: Phenol, 2-amino-6-(1-methylethyl)- (9CI)
• Synonyms: Phenol, 2-amino-6-(1-methylethyl)- (9CI);2-AMINO-6-ISOPROPYL-PHENOL
• CAS NO: 29078-20-4
• Molecular Formula: C₉H₁₃NO
• Molecular Weight: 151.20562
• Product Categories: ISOPROPYL
• Mol File: 29078-20-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Phenol, 2-amino-6-(1-methylethyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2-amino-6-(1-methylethyl)- (9CI)(29078-20-4)
• EPA Substance Registry System: Phenol, 2-amino-6-(1-methylethyl)- (9CI)(29078-20-4)

Safety Data

• Hazardous Substances Data: 29078-20-4(Hazardous Substances Data)

Upstream product

• 7545-71-3 2-isopropyl-6-nitrophenol 
• 127293-44-1 4-bromo-2-isopropyl-6-nitrophenol 

Downstream Products

• 112808-55-6 2-(2-bromo-3-methylbutyryl)amino-6-isopropylphenol 
• 112808-22-7 AD 5467 
• 461701-21-3 N₂-(4-bromophenyl)-7-isopropyl-1,3-benzoxazol-2-amine 

Relevant articles and documents

Nitrogen-containing fused ring compounds and use thereof

A URAT1 activity inhibitor containing a nitrogen-containing fused ring compound represented by the following formula [1]: wherein each symbol is as defined in the description. The present invention is useful for the prophylaxis or treatment of pathology showing involvement of uric acid, such as hyperuricemia, gouty tophus, acute gouty arthritis, chronic gouty arthritis, gouty kidney, urolithiasis, renal function disorder, coronary artery disease, ischemic heart disease and the like.

Pyrazolopyrimidines as therapeutic agents

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

Pyrazolopyrimidines as therapeutic agents

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.